Coexpression of the melatonin receptor 1 and nestin in human breast cancer specimens

Journal of Pineal Research

Volumn 46, Issue 4, 2009, Pages 422-432

  Rogelsperger O ^a   Ekmekcioglu, C ^a   Jager W ^b   Klimpfinger, M ^a,c   Konigsberg R ^d   Krenbek, D ^a   Sellner, F ^e   Thalhammer, T ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c Institute of Pathology and Bacteriology   (Austria)

^d LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^e Clinic for Surgery Ophthalmology and Dentistry   (Austria)

Author keywords

Breast cancer; Immunofluorescence; MT1 nestin coexpression; Quantification; Tissue Quest

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; MELATONIN 1 RECEPTOR; NESTIN;

ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST DUCT; CANCER CELL; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MYOEPITHELIUM CELL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ACTINS; ADULT; AGED; BREAST NEOPLASMS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; MIDDLE AGED; NEOPLASM STAGING; NEPRILYSIN; NERVE TISSUE PROTEINS; RECEPTOR, MELATONIN, MT1; STATISTICS, NONPARAMETRIC;

EID: 64649086787     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2009.00679.x     Document Type: Article

References (44)

1. Tan DX, Manchester LC, Terron MP et al. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007 42 : 28 42.
2. Peyrot F, Ducrocq C. Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species. J Pineal Res 2008 45 : 235 246.
3. Witt-Enderby PA, Radio NM, Doctor JS et al. Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy. J Pineal Res 2006 41 : 297 305.
4. Srinivasan V, Spence DW, Pandi-Perumal SR et al. Therapeutic actions of melatonin in cancer: possible mechanisms. Integr Cancer Ther 2008 7 : 189 203.
5. Korkmaz A, Sanchez-Barcelo EJ, Tan DX et al. Role of melatonin in the epigenetic regulation of breast cancer. Breast Cancer Res Treat 2008, published online July 2008.
6. Lai L, Yuan L, Chen Q et al. The Galpha(i) and Galpha(q) proteins mediate the effects of melatonin on steroid/thyroid hormone receptor transcriptional activity and breast cancer cell proliferation. J Pineal Res 2008 45 : 476 488.
7. Toma CD, Svoboda M, Arrich F et al. Expression of the melatonin receptor (MT) 1 in benign and malignant human bone tumors. J Pineal Res 2007 43 : 206 213.
8. Yuan L, Collins AR, Dai J et al. MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells. Mol Cell Endocrinol 2002 192 : 147 156.
9. Kiefer T, Ram PT, Yuan L et al. Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells. Breast Cancer Res Treat 2002 71 : 37 45.
10. Cos S, Gonzalez A, Martinez-Campa C et al. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions. Cancer Detect Prev 2006 30 : 118 128.
11. Allred DC, Brown P, Medina D. The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer. Breast Cancer Res 2004 6 : 240 245.
12. Dillon DC, Easley SE, Asch BB et al. Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue. Am J Clin Pathol 2002 118 : 451 458.
13. Kiefer TL, Lai L, Yuan L et al. Differential regulation of estrogen receptor alpha, glucocorticoid receptor and retinoic acid receptor alpha transcriptional activity by melatonin is mediated via different G proteins. J Pineal Res 2005 38 : 231 239.
14. Blask DE, Brainard GC, Dauchy RT et al. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res 2005 65 : 11174 11184.
15. Bellon A, Ortiz-Lopez L, Ramirez-Rodriguez G et al. Melatonin induces neuritogenesis at early stages in N1E-115 cells through actin rearrangements via activation of protein kinase C and Rho-associated kinase. J Pineal Res 2007 42 : 214 221.
16. Sainz RM, Mayo JC, Tan DX et al. Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism. Prostate 2005 63 : 29 43.
17. Bondi CD, Mckeon RM, Bennett JM et al. MT1 melatonin receptor internalization underlies melatonin-induced morphologic changes in Chinese hamster ovary cells and these processes are dependent on Gi proteins, MEK 1/2 and microtubule modulation. J Pineal Res 2008 44 : 288 298.
18. Roka F, Brydon L, Waldhoer M et al. Tight association of the human Mel(1a)-melatonin receptor and G(i): precoupling and constitutive activity. Mol Pharmacol 1999 56 : 1014 1024.
19. Jockers R, Maurice P, Boutin JA et al. Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? Br J Pharmacol 2008 154 : 1182 1195.
20. Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea - a paradigm shift. Cancer Res 2006 66 : 1883 1890. discussion 95-6.
21. Gonzalez-Sarmiento R, Perez-Losada J. Breast cancer, a stem cell disease. Curr Stem Cell Res Ther 2008 3 : 55 65.
22. Hombach-Klonisch S, Panigrahi S, Rashedi I et al. Adult stem cells and their trans-differentiation potential-perspectives and therapeutic applications. J Mol Med 2008 86 : 1301 1314.
23. Parry S, Savage K, Marchio C et al. Nestin is expressed in basal-like and triple negative breast cancers. J Clin Pathol 2008 61 : 1045 1050.
24. Li H, Cherukuri P, Li N et al. Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors. Cancer Res 2007 67 : 501 510.
25. Bussolati B, Grange C, Sapino A et al. Endothelial cell differentiation of human breast tumor stem/progenitor cells. J Cell Mol Med 2008 13 : 309 319.
26. Niles LP, Armstrong KJ, Rincon Castro LM et al. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers. BMC Neurosci 2004 5 : 41.
27. Königsberg R, Rogelsperger O, Jager W et al. Cell cycle dysregulation influences survival in high risk breast cancer patients. Cancer Invest 2008 26 : 734 740.
28. Goldhirsch A, Glick JH, Gelber RD et al. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 2005 16 : 1569 1583.
29. Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 1987 8 : 138 140.
30. Steiner GE, Ecker RC, Kramer G et al. Automated data acquisition by confocal laser scanning microscopy and image analysis of triple stained immunofluorescent leukocytes in tissue. J Immunol Methods 2000 237 : 39 50.
31. Polyak K, Hu M. Do myoepithelial cells hold the key for breast tumor progression? J Mammary Gland Biol Neoplasia 2005 10 : 231 247.
32. Fridriksdottir AJ, Villadsen R, Gudjonsson T et al. Maintenance of cell type diversification in the human breast. J Mammary Gland Biol Neoplasia 2005 10 : 61 74.
33. Booth BW, Mack DL, Androutsellis-Theotokis A et al. The mammary microenvironment alters the differentiation repertoire of neural stem cells. Proc Natl Acad Sci USA 2008 105 : 14891 14896.
34. Kumar R, Wang RA. Protein kinases in mammary gland development and cancer. Microsc Res Tech 2002 59 : 49 57.
35. Andrechek ER, Muller WJ. Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer. Breast Cancer Res 2000 2 : 211 216.
36. Neve RM, Lane HA, Hynes NE. The role of overexpressed HER2 in transformation. Ann Oncol 2001 12 (Suppl. 1 S9 S13.
37. Toker A, Yoeli-Lerner M. Akt signaling and cancer: surviving but not moving on. Cancer Res 2006 66 : 3963 3966.
38. Witt-Enderby PA, Bennett J, Jarzynka MJ et al. Melatonin receptors and their regulation: biochemical and structural mechanisms. Life Sci 2003 72 : 2183 2198.
39. Von Gall C, Stehle JH, Weaver DR. Mammalian melatonin receptors: molecular biology and signal transduction. Cell Tissue Res 2002 309 : 151 162.
40. Martinez-Campa C, Alonso-Gonzalez C, Mediavilla MD et al. Melatonin inhibits both ER alpha activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium. J Pineal Res 2006 40 : 291 296.
41. Shiu SY, Law IC, Lau KW et al. Melatonin slowed the early biochemical progression of hormone-refractory prostate cancer in a patient whose prostate tumor tissue expressed MT1 receptor subtype. J Pineal Res 2003 35 : 177 182.
42. Yang XH, Wu QL, Yu XB et al. Nestin expression in different tumours and its relevance to malignant grade. J Clin Pathol 2008 61 : 467 473.
43. Gerhardt H, Semb H. Pericytes: gatekeepers in tumour cell metastasis? J Mol Med 2008 86 : 135 144.
44. Sledge GW Jr., Rugo HS, Burstein HJ. The role of angiogenesis inhibition in the treatment of breast cancer. Clin Adv Hematol Oncol 2006 4 : 1 10. quiz 11-2.